Screening Rates Authors: Budd AC1, Brotherton JM2, Gertig DM2, Chau T3, Drennan KT2, Saville M2 Abstract OBJECTIVE: To compare cervical screening rates for women vaccinated with a quadrivalent human papillomavirus (HPV) vaccine with those for unvaccinated women, to address concerns that vaccinated women may not be participating in cervical screening. DESIGN, SETTING AND PARTICIPANTS: Cross-sectional […]
Michele Rivasi addresses the Gardasil scandal in Europe
Gardasil Scandal [Note from SaneVax: What is the justification for using HPV vaccines? What is the benefit/risk profile? What place do HPV vaccines have in the cervical cancer prevention strategy, and at what cost? Is Gardasil a cervical cancer vaccine or a cancer of policies? Where are medical ethics in cervical cancer prevention plans? More […]
Cytokine levels in cervical cancers: HPV 16-18 vs non HPV 16-18 genotypes
IL-10, IL-15, IL-17, and GMCSF levels in cervical cancer tissue of Tanzanian women infected with HPV16-18 vs. non-HPV16-18 genotypes By Adriana C Vidal1, David Skaar2, Rachel Maguire2, Seyram Dodor3, Laura W Musselwhite4, John A Bartlett5, Olola Oneko6, Joseph Obure6, Pendo Mlay6, Susan K Murphy7 and Cathrine Hoyo2* Abstract Background Despite comparable screening rates for precancerous lesions, […]
Human adjuvant related syndrome or autoimmune/inflammatory syndrome induced by adjuvants
Human adjuvant related syndrome or autoimmune/inflammatory syndrome induced by adjuvants Adjuvant Related Syndrome. Where have we come from? Where are we going? A proposal for new diagnostic criteria. By Alijotas-Reig J. Lupus. 2015. Abstract In 1964, Miyoshi reported a series of patients with diverse symptoms after receiving treatment with silicone or paraffin fillers. Miyoshi named this […]
Suspected side effects to the quadrivalent human papilloma vaccine, Gardasil
Quadrivalent human papilloma vaccine By Louise Brinth1, 2, Ann Cathrine Theibel1, 2, Kirsten Pors1, & Jesper Mehlsen1, 2 1) Coordinating Research Centre/Syncope Unit, Grederiksberg Hospital; 2) Department of Clinical Physiology and Nuclear Medicine, Frederiksberg Hospital, Denmark Abstract Introduction: The quadrivalent vaccine that protects against human papilloma virus types 6, 11, 16 and 18 (Q-HPV vaccine, Gardasil) […]
- « Previous Page
- 1
- …
- 29
- 30
- 31
- 32
- 33
- …
- 448
- Next Page »
